2007
DOI: 10.2169/internalmedicine.46.0064
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment with Infliximab and Low-dose Methotrexate in a Japanese Patient with Familial Mediterranean Fever

Abstract: We report a Japanese patient with familial Mediterranean fever (FMF)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0
1

Year Published

2010
2010
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 15 publications
0
17
0
1
Order By: Relevance
“…We used infliximab first because the effectiveness of the drug in a Japanese FMF patient was previously reported (19). Infliximab dramatically alleviated the patient's symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…We used infliximab first because the effectiveness of the drug in a Japanese FMF patient was previously reported (19). Infliximab dramatically alleviated the patient's symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…However, it is difficult to obtain anakinra in Japan. Anti-TNF agents, including infliximab, etanercept, adalimumab and golimumab, can also be employed to control FMF attacks quite effectively (19,20). In the present case, following the administration of 1 mg of colchicine and treatment with infliximab for seven months, we increased the dose of colchicine to 1.5 mg and discontinued infliximab.…”
Section: Discussionmentioning
confidence: 70%
“…[16] Tumor necrosis factor alpha inhibitors have been reported to be effective in the treatment of FMF in many case reports. [4,[9][10][11][12] Most of the patients were treated with infliximab, and one patient was treated with etanercept. [9] Our patient responded to TNF-α (adalimumab) treatment.…”
Section: Discussionmentioning
confidence: 99%
“…There are a few reports of FMF cases that were treated with a tumor necrosis factor alpha (TNF-α) inhibitor. [4,[9][10][11][12] In this article, we report on a patient who was followed up after a diagnosis of AS for two years, diagnosed with FMF in our clinic and who responded to adalimumab treatment.…”
mentioning
confidence: 99%